Home Abstract

Bioflavonoids Inhibits Dipeptidyl Peptidase-IV Expressions in Diabetic Rats

Received On: 27/12/2013
Accepted On: 30/12/2013


Shankaraiah, P., Reddy, Y. N.

Author's Affiliation


The study aim is to investigate the Dipeptidyl peptidase-iv inhibitory activity, antidyslipidemic and anti diabetic effects of the flavonoids (Quercetin, Chrysin & Hesperdin) in alloxan-induced diabetic rats. The effects of orally administered flavonoids (Quercetin, Chrysin & Hesperdin) on serum glucose and antidyslipidemic activity were examined in diabetic control and flavonoids treated diabetic rats. While the activities of the Dipeptidyl peptidase-iv levels, Lipid profiles in the serum were assessed. The flavonoids were administered over a period of 21 days. Results involves the quercetin, chrysin & Hesperdins were significantly (P<0.05) reduced serum glucose, Dipeptidyl peptidase-iv activity and dyslipidemic status in all the flavonoids and pioglitazone treated groups. Conclusions of the present investigation suggests that flavonoids and pioglitazone combination with flavonoids was inhibits Dipeptidyl peptidase-iv activity, dyslipidemic status and hypoglycemic effect in diabetes rats.


DPP-IV, Flavonoids, Blood Glucose, Lipid Profiles

Cite This Article

Shankaraiah, P., & Reddy, Y. N. (2013). Bioflavonoids Inhibits Dipeptidyl Peptidase-IV Expressions in Diabetic Rats. International Journal for Pharmaceutical Research Scholars (IJPRS), 2(4), 390-397.

Recent Articles

Get FREE Updates for Upcoming
Pharma News, Jobs & Conferences

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

IJPRS will use the information you provide on this form to be in touch with you and to provide updates and marketing.